ISSN: 0976-500X
Journal Home
Journal Guideline
Journal of Pharmacology and Pharmacotherapeutics Q4 Unclaimed
Journal of Pharmacology and Pharmacotherapeutics is a journal indexed in SJR in Pharmacology and Pharmacology (medical) with an H index of 42. It has an SJR impact factor of 0,128 and it has a best quartile of Q4. It has an SJR impact factor of 0,128.
Type: Journal
Type of Copyright:
Languages:
Open Access Policy:
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,128
SJR Impact factor42
H Index29
Total Docs (Last Year)124
Total Docs (3 years)980
Total Refs35
Total Cites (3 years)113
Citable Docs (3 years)0.32
Cites/Doc (2 years)33.79
Ref/DocOther journals with similar parameters
Bangladesh Journal of Pharmacology Q4
European Journal of Oncology Pharmacy Q4
Pharmaceutical Chemistry Journal Q4
Prescrire International Q4
Biomedical and Pharmacology Journal Q4
Compare this journals
Aims and Scope
Best articles by citations
Aspartame: Sweetener with anti-inflammatory potential?
View moreTherapeutic drug monitoring of modified release once daily tacrolimus in de novo renal transplant with conversion to a twice daily generic in the stable period
View moreThe incidence and nature of drug-related hospital admission: A 6-month observational study in a tertiary health care hospital
View moreAssessment of demographics, treatment strategies, and evidence-based medicine use among diabetic and non-diabetic patients with acute coronary syndrome: A cohort study
View moreA study of adverse drug reactions in pediatric patients
View moreCarbamazepine-induced hypertension: A rare case
View moreIntern doctors' feedback on teaching methodologies in pharmacology
View moreA comparative study of the clinical efficacy and safety of agomelatine with escitalopram in major depressive disorder patients: A randomized, parallel-group, phase IV study
View moreFrequency distribution
View moreIdentification and characterization of primate P-glycoprotein
View moreAgomelatine: A novel melatonergic antidepressant
View moreAssessment of aromatase inhibitor-induced bone loss and appropriateness of supportive therapy in postmenopausal breast cancer patients at a tertiary care center
View moreOnline videos as a supplement tool to train II MBBS students in drug administration skills
View moreMirtazapine withdrawal-induced mania
View moreCommittee on publication ethics
View moreAnalysis of thyroid function tests in patients of multidrug resistance tuberculosis undergoing treatment
View moreAre we moving towards a new definition of essential medicines?
View moreInhibition by sildenafil of contractility of isolated non-pregnant human myometrium
View moreCarbimazole-induced agranulocytosis
View moreRemembering what's new in Alzheimer's management
View moreAdverse drug reaction monitoring in a tertiary care teaching hospital
View moreData transformation
View moreFolic acid supplementation on homocysteine levels in children taking antiepileptic drugs: A randomized controlled trial
View moreAdverse drug reactions in inpatients of internal medicine wards at a tertiary care hospital: A prospective cohort study
View more
Comments